Moderna's $8B Balance Rose With Financing. Check the Cash Flow.

A larger financial cushion can be useful, but it does not identify where the money came from. Before calling a rising balance evidence of cash generation, inspect what the balance contains, then separate financing from the operating cash-flow statement. Moderna's new results make that distinction concrete.

Original SignalSage financial diagram for Moderna. Sep30 2026: cash and equivalents $1,195M, current investments $3,976M, non-current investments $2,805M; total $7,976M rounds to $8.0B. A separate funding row identifies about $2.6B net convertible-note/capped-call proceeds. The operating cash-used row labels $2,715M as Jan-Sep, not Q3 alone. Nov6 release/Nov7 Beijing review. No invented cash-burn residual, stock forecast or app calculation.

Start with the dated balance

Moderna announced its third-quarter results on November 6, 2026. This is a November 7 Beijing review of the quarter ended September 30. The release describes cash, cash equivalents and investments of $8.0 billion, compared with $6.9 billion at June 30. The $1.1 billion increase is arithmetic on rounded disclosed balances. It is not a reported operating cash-flow total.

Open the three compartments

The September 30 balance sheet lists $1,195 million of cash and cash equivalents, $3,976 million of current investments, and $2,805 million of non-current investments. Together, these are $7,976 million, which rounds to the $8.0 billion headline. Calling the whole amount cash and equivalents would erase the investment categories. Keep the exact balance-sheet labels beside your numbers.

Trace the funding separately

The release attributes the increase primarily to approximately $2.6 billion of net proceeds from convertible notes and related capped call transactions. It also describes a $950 million litigation settlement payment and cash used in operations as offsets. Financing can enlarge a balance while the business uses cash. The funding source belongs in the research question, not in a footnote discarded after reading the headline.

Do not manufacture the missing bridge

Subtracting the disclosed settlement payment from the financing proceeds will not, by itself, reconcile the change in a balance that includes investments. Rounded figures, investment movements and other cash flows require their own consistent treatment. Do not label an unexplained residual operating cash burn. Start with the issuer's cash-flow statement and check the reconciliation boundary before calculating a bridge.

Keep the period attached

The attached cash-flow statement reports $2,715 million of cash used in operating activities for the nine months ended September 30, 2026. That is January through September, not the third quarter alone. A quarter-to-quarter balance comparison and a nine-month flow can both be relevant, but cannot silently become the same measurement window.

A practical research receipt

After a stock screen, make four entries in your own research notes: the balance's exact label, its as-of date, the funding source, and the cash-flow period. Then ask whether the next filing shows operating collections and uses changing in the direction your thesis requires. This suggested workflow does not establish a stock valuation, predict returns, or demonstrate a new app calculation or note-taking feature.

Continue with the original evidence

SignalSage by MerlaTech supports US Stock Research and AI Stock Analysis. English interface; some features require in-app purchases or subscriptions. Use the iPhone and Android download hub and existing screener walkthrough below. This original explanation and animation are AI-assisted, with synthetic English narration and original synthesized music. The discussion concerns financial statements, not medical efficacy or treatment decisions.

Primary sources and next steps

Moderna November6 Q3 release, balance sheet and nine-month cash-flow statement

Moderna November6 Form8-K, Item2.02 and furnished Exhibit99.1

SignalSage for iPhone and Android

Android on Google Play

Existing screener walkthrough

Watch the original 90-second Moderna balance and cash-flow animation

Comments

Post a Comment

Popular posts from this blog

Dividend Yield Doubled, Dividend Did Not: A Research Checklist

Image
A stock's displayed dividend yield can double without an increase in its dividend per share. This fictional case separates the cash amount, the share price and the percentage, then gives you a research note you can copy. By the MerlaTech team. Fictional common-stock example in US dollars, not a recommendation about any security. Same annual dividend per share; a different price denominator. Original AI-assisted MerlaTech illustration. Tap the image to see the full-size version. 1. Rebuild the ratio Dividend yield (%) = annual dividend per share ÷ current share price × 100. FINRA explains that yield changes with both the dividend and the security's price. Read FINRA's explanation of investment value and yield. In our example, $4 ÷ $100 = 4%. At a $50 share price, the same $4 gives $4 ÷ $50 = 8%. The yield rose by 4 percentage points , or doubled in relative terms. The dividend per share did not change. Fictional comparison scenarios, not forecasts Scenario Share pri...
Read more

Profit Isn't Cash: A Three-Statement Research Note

Image
Before copying a number into your company research, write down which statement it came from and what time frame it describes. This small step makes the note easier to check later. Three statements, three different questions. Tap the graphic to view it at full size. Educational graphic by the MerlaTech team, prepared with AI assistance; not an app screenshot. Three questions to keep separate Balance sheet: What assets, obligations and equity are reported at the stated date? Income statement: What revenue, expenses and profit or loss are reported for the stated period? Cash flow statement: How did cash move through operating, investing and financing activities during that period? A profit figure does not describe the same thing as cash generated. A balance-sheet date also describes a different time frame from a quarter or year of activity. These three statements are a starting point; companies also report changes in shareholders' equity. This distinction follows the SEC...
Read more

Sales Down 10%, Operating Profit Down 40%: Test the Fixed-Cost Assumptions

Image
By the MerlaTech team behind SignalSage. Original fictional examples; AI-assisted illustration and writing. A 10% sales decline does not necessarily imply a 10% decline in operating profit. A company still has to cover costs that do not shrink with that quarter's sales. This worksheet isolates that effect with three transparent scenarios, so the assumptions are easy to challenge. Fictional annual USD-million example. The illustrated factory is not a real business or an app screenshot. One cost structure, three scenarios Assume sales change only because volume changes. Selling price, product mix and variable cost per unit stay unchanged. Total variable costs are therefore 60% of revenue. Fixed operating costs remain $30 million throughout the illustrated range. All figures use the same annual period and currency. USD millions Downside Base Upside Revenue 90 100 110 Variable costs 54 60 66 Fixed costs 30 30 30 Operating profit 6 10 14 Base: 100 − 60 − 30 = 10. Downside: 90 − 54...
Read more